Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition

Jennings, VA, Scott, GB orcid.org/0000-0003-0021-9400, Rose, AMS et al. (13 more authors) (2019) Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular Therapy, 27 (6). ISSN 1525-0024

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: oncolytic virus; herpes simplex virus; HSV,cancer immunotherapy; histone deacetylase inhibitor; valproic acid; VPA
Dates:
  • Published: 5 June 2019
  • Accepted: 8 April 2019
  • Published (online): 14 April 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Biomarkers and Therapy (Leeds)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchNot Known
Cancer Research UKC50189/A22951
Depositing User: Symplectic Publications
Date Deposited: 09 Apr 2019 12:15
Last Modified: 18 Feb 2020 12:56
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ymthe.2019.04.008

Share / Export

Statistics